Asymmetric sensorineural hearing loss is a risk factor for late-onset hearing loss in pediatric cancer survivors following cisplatin treatment

Margaret S. Robertson, Susan S. Hayashi, Miranda L. Camet, Kathryn Trinkaus, Jennifer Henry, Robert J. Hayashi

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Asymmetric sensorineural hearing loss is a risk factor for late-onset hearing loss in pediatric cancer survivors following cisplatin treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences